Published in Breast Cancer Res on March 14, 2003
Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family. Biol Chem (2010) 1.07
Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth. J Cell Sci (2010) 1.02
The Matricellular Receptor LRP1 Forms an Interface for Signaling and Endocytosis in Modulation of the Extracellular Tumor Environment. Front Pharmacol (2015) 0.78
Roles of low-density lipoprotein receptor-related protein 1 in tumors. Chin J Cancer (2016) 0.76
Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant. PLoS One (2017) 0.75
The LRP1 Gene Polymorphism is associated with Increased Risk of Metabolic Syndrome Prevalence in the Serbian Population. Balkan J Med Genet (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell (1991) 9.73
Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res (1985) 8.64
AP-1 in cell proliferation and survival. Oncogene (2001) 6.07
LRP: a multifunctional scavenger and signaling receptor. J Clin Invest (2001) 5.31
CD91: a receptor for heat shock protein gp96. Nat Immunol (2000) 3.78
Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today (2000) 2.44
Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J Biol Chem (2000) 2.18
Candidate genes for the hypoxic tumor phenotype. Cancer Res (2000) 1.94
Cancer invasion and tissue remodeling--cooperation of protease systems and cell types. APMIS (1999) 1.77
Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology (1997) 1.58
Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev (2000) 1.54
Demonstration of an alpha2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. J Biol Chem (1979) 1.45
Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J Biol Chem (1999) 1.36
Tyrosine-phosphorylated low density lipoprotein receptor-related protein 1 (Lrp1) associates with the adaptor protein SHC in SRC-transformed cells. J Biol Chem (2001) 1.35
Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells. J Biol Chem (1994) 1.30
Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol (1999) 1.30
Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol (2002) 1.29
Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. Am J Pathol (2002) 1.24
Evidence of functional modulation of the MEKK/JNK/cJun signaling cascade by the low density lipoprotein receptor-related protein (LRP). J Biol Chem (2002) 1.12
Genomic organization of a new candidate tumor suppressor gene, LRP1B. Genomics (2000) 1.07
Alteration of the LRP1B gene region is associated with high grade of urothelial cancer. Lab Invest (2002) 1.05
Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas. Cancer Res (1997) 1.00
Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology (1998) 1.00
Phosphorylation of LRP1: regulation of transport and signal transduction. Trends Cardiovasc Med (2002) 0.97
Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein. Eur J Biochem (1997) 0.96
The C766T low-density lipoprotein receptor related protein polymorphism and coronary artery disease, plasma lipoproteins, and longevity in the Czech population. J Mol Med (Berl) (2001) 0.86
Low density lipoprotein receptor related protein gene amplification and 766T polymorphism in astrocytomas. Neurosci Lett (1998) 0.85
In vitro invasiveness of human breast cancer cells is promoted by low density lipoprotein receptor-related protein. Invasion Metastasis (2000) 0.83
Low density lipoprotein receptor-related protein (LRP) expression varies among Hep G2 cell lines. Thromb Res (1997) 0.80
Cell density and oestrogen both stimulate alpha 2-macroglobulin receptor expression in breast cancer cell T-47D. Anticancer Res (1998) 0.80
Presence of alpha 2-macroglobulin in normal but not in malignant human syncytiotrophoblasts. Cancer Res (1981) 0.80
Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet (2002) 0.98
A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease. Matrix Biol (2004) 0.95
Lack of association between atopic asthma and the tumor necrosis factor alpha-308 gene polymorphism in a Czech population. J Investig Allergol Clin Immunol (2002) 0.85
Topography of genetic loci in the nuclei of cells of colorectal carcinoma and adjacent tissue of colonic epithelium. Chromosoma (2004) 0.84
Genetic variation in the promoter region of the basic fibroblast growth factor gene. Hum Immunol (2003) 0.83
Drugs elevating extracellular adenosine promote regeneration of haematopoietic progenitor cells in severely myelosuppressed mice: their comparison and joint effects with the granulocyte colony-stimulating factor. Eur J Haematol (2002) 0.82
Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure. Clin Chem Lab Med (2003) 0.80
ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis. Kidney Blood Press Res (2012) 0.79
Endothelin-1 gene polymorphism in patients with malignant arrhythmias. J Cardiovasc Pharmacol (2004) 0.78
Correlations of breast carcinoma biomarkers and p53 tested by FASAY and immunohistochemistry. Pathol Res Pract (2003) 0.77
Haplotype analysis of the endothelial nitric oxide synthase gene in asthma. Hum Immunol (2008) 0.76
Isolation of metallothionein from cells derived from aggressive form of high-grade prostate carcinoma using paramagnetic antibody-modified microbeads off-line coupled with electrochemical and electrophoretic analysis. Electrophoresis (2011) 0.75
Period3 VNTR polymorphism influences the time-of-day pain onset of acute myocardial infarction with ST elevation. Chronobiol Int (2014) 0.75
Three novel polymorphisms in the promoter region of the TIMP-3 gene are not associated with proliferative diabetic retinopathy in type 2 diabetes mellitus. Curr Eye Res (2003) 0.75
[Surgical oncology. History, definition, content and perspective]. Rozhl Chir (2007) 0.75
Preoperative hypoxyradiotherapy of colorectal carcinoma. Strahlenther Onkol (2002) 0.75
The role of the IKAP gene polymorphisms in atopic diseases in the middle European population. J Hum Genet (2003) 0.75
[Concomitant chemoradiotherapy of solid tumors. Introduction]. Cas Lek Cesk (2003) 0.75
[Data for surgery]. Rozhl Chir (2015) 0.75
Endothelin-1 gene polymorphism in the identification of patients at risk for malignant ventricular arrhythmia. Med Sci Monit (2002) 0.75
Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide. Neuro Endocrinol Lett (2012) 0.75
Altered cannabinoid CB1 receptor mRNA expression in mesencephalon from mice exposed to repeated methamphetamine and methanandamide treatments. Neuro Endocrinol Lett (2011) 0.75